$18.51
0[0.00%]
At close: Apr 18
$18.51
0[0.00%]
PreMarket: 4:20PM EDT
Myriad Genetics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Myriad Genetics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/01/2024 | PM | MYGN | Q1 | -$0.21 | -$0.10 | — | — | $181.20M | $193.26M | — | — | Get Alert |
02/27/2024 | PM | MYGN | Q4 | -$0.12 | $0.01 | $0.04 | 300.00% | $177.80M | $194.78M | $196.60M | 0.93% | Get Alert |
11/06/2023 | PM | MYGN | Q3 | -$0.19 | -$0.08 | -$0.03 | 62.50% | $156.40M | $179.25M | $191.90M | 7.06% | Get Alert |
08/03/2023 | PM | MYGN | Q2 | $0.04 | -$0.08 | -$0.08 | 0.00% | $179.30M | $187.13M | $183.50M | -1.94% | Get Alert |
05/03/2023 | PM | MYGN | Q1 | -$0.03 | -$0.19 | -$0.21 | -10.53% | $164.90M | $171.55M | $181.20M | 5.63% | Get Alert |
02/28/2023 | PM | MYGN | Q4 | -$0.02 | -$0.16 | -$0.12 | 25.00% | $160.80M | $169.46M | $177.80M | 4.92% | Get Alert |
11/01/2022 | AM | MYGN | Q3 | -$0.02 | -$0.06 | -$0.19 | -216.67% | $167.30M | $170.10M | $156.40M | -8.05% | Get Alert |
08/04/2022 | AM | MYGN | Q2 | $0.12 | $0.01 | $0.04 | 300.00% | $189.40M | $171.00M | $179.30M | 4.85% | Get Alert |
05/05/2022 | AM | MYGN | Q1 | -$0.06 | -$0.07 | -$0.03 | 57.14% | $173.10M | $156.62M | $164.90M | 5.29% | Get Alert |
02/24/2022 | AM | MYGN | Q4 | -$0.31 | -$0.02 | -$0.02 | 0.00% | $93.20M | $163.40M | $160.80M | -1.59% | Get Alert |
11/02/2021 | AM | MYGN | Q3 | -$0.08 | -$0.02 | -$0.02 | 0.00% | $164.00M | $165.04M | $167.30M | 1.37% | Get Alert |
08/03/2021 | AM | MYGN | Q2 | $0.23 | -$0.09 | $0.12 | 233.33% | $195.10M | $165.39M | $189.40M | 14.52% | Get Alert |
05/03/2021 | PM | MYGN | Q1 | $0.08 | -$0.14 | -$0.06 | 57.14% | $186.30M | $156.20M | $173.10M | 10.82% | Get Alert |
02/23/2021 | PM | MYGN | Q2 | $0.23 | -$0.12 | -$0.12 | 0.00% | $195.10M | $150.39M | $154.60M | 2.80% | Get Alert |
11/09/2020 | AM | MYGN | Q1 | $0.08 | -$0.30 | -$0.15 | 50.00% | $186.30M | $135.21M | $145.20M | 7.39% | Get Alert |
08/13/2020 | PM | MYGN | Q4 | $0.41 | -$0.47 | -$0.31 | 34.04% | $215.40M | $93.85M | $93.20M | -0.69% | Get Alert |
05/05/2020 | PM | MYGN | Q3 | $0.46 | $0.02 | -$0.08 | -500.00% | $216.60M | $167.19M | $164.00M | -1.91% | Get Alert |
02/06/2020 | PM | MYGN | Q2 | $0.38 | $0.31 | $0.23 | -25.81% | $216.80M | $209.81M | $195.10M | -7.01% | Get Alert |
11/04/2019 | PM | MYGN | Q1 | $0.43 | $0.32 | $0.08 | -75.00% | $202.30M | $202.10M | $186.30M | -7.82% | Get Alert |
Myriad Genetics (MYGN) is scheduled to report earnings on May 1, 2024. The last reported earnings were for reported on February 27, 2024 for Q4.
The Actual EPS was $0.04, which beat the estimate of $0.01.
The Actual Revenue was $196.6M, which beat the estimate of $194.8M.
Browse earnings estimates, EPS, and revenue on all stocks.